0022-3565/00/2933-0788$03.

00/0 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Copyright 2000 by The American Society for Pharmacology and Experimental Therapeutics JPET 293:788798, 2000 /2173/823032

Vol. 293, No. 3 Printed in U.S.A.

Ca2 Signaling via 1-Receptors: Novel Regulatory Mechanism Affecting Intracellular Ca2 Concentration1
TERUO HAYASHI, TANGUI MAURICE, and TSUNG-PING SU
Cellular Pathobiology Unit, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland (T.H., T.-P.S.); and Institut National de la Sante et de la Recherche Medicale, Unite 336-Developpement, Vieillissement et Plasticite du Systme Nerveux, Montpellier, France (T.M.) Accepted for publication February 1, 2000 This paper is available online at http://www.jpet.org

ABSTRACT The 1-receptor is a one-transmembrane endoplasmic reticulum protein that binds neurosteroids and dextrorotatory benzomorphans. The roles of 1-receptors in regulating intracellular Ca2 in NG108 cells were examined in this study. 1-Ligands pregnenolone sulfate, ( )-pentazocine, and 2-(4-morpholino)ethyl-1phenylcyclohexane-1-carboxylate hydrochloride modulate Ca2 signaling in NG108 cells via two modes of action. First, nanomolar concentrations of the ligands, without effect by themselves, potentiated the bradykinin-induced increase of the cytosolic free Ca2 concentration in a bell-shaped manner. This effect of 1ligands was unaffected by depletion of Ca2 from perfusion buffer and was blocked by a 21-mer antisense oligodeoxynucleotide against the cloned 1-receptors. Second, after the cells were

depleted of the endoplasmic reticulum Ca2 stores, the depolarization (75 mM KCl)-induced increase in cytosolic free Ca2 was potentiated by 2-(4-morpholino)ethyl-1-phenylcyclohexane-1carboxylate hydrochloride, whereas it was inhibited by pregnenolone sulfate and ( )-pentazocine. These effects, albeit opposite in direction, were blocked by both the 21-mer antisense oligodeoxynucleotide and pertussis toxin. Western blotting indicates that 1-receptors are increased on the plasma membrane and the nuclear membrane in the presence of 1-ligand. These results suggest that Ca2 signaling via 1-receptors may represent a novel mechanism that affects intracellular Ca2 concentrations.

1-Receptors are a subtype of -receptors known to bind diverse classes of pharmacological agents with high affinity. These agents include neurosteroids, antipsychotics, and dextrorotatory benzomorphans (Snyder and Largent, 1989; Su, 1991). -Receptors are not the /opioid receptors originally proposed by Martin et al. (1976) to mediate psychotomimetic effects of benzomorphans. 1-Receptors are currently thought to be involved, among other functions, in learning and memory as well as in the analgesic processes of animals (Chien and Pasternak, 1994; Maurice et al., 1994, 1998; Bouchard et al., 1997). The 1-receptor has been cloned (Hanner et al., 1996; Prasad et al., 1998). The deduced amino acid sequence does not resemble that of any mammalian protein. The sequence of 1-receptors contains an endoplasmic reticulum (ER) re-

Received for publication October 6, 1999. 1 This study was supported by the Intramural Research Program of the National Institute on Drug Abuse/National Institutes of Health. The partial supports of the Division of Basic Research (Basic Neurobiology and Biological Systems Research Branch), National Institute on Drug Abuse/National Institutes of Health, and the Pharmacopsychiatry Research Foundation of Japan are appreciated.

tention signal close to the N terminus, a binding domain for steroid, and one putative transmembrane region. Although the cloned 1-receptor has a 30% identity and a 60% homology to a yeast C7-C8 sterol isomerase, 1-receptors apparently possess no similar enzymatic activity. Furthermore, the mammalian equivalent of the C7-C8 sterol isomerase has been cloned and the deduced amino acid sequence is different from that of both the yeast C7-C8 sterol isomerase and the 1-receptor (Silve et al., 1996). Thus, although the structure of 1-receptors is known, the biochemical basis subserving the action of 1-receptors remains elusive. Several lines of evidences have suggested that -receptors may be related to the regulation of intracellular Ca2 . For example, exposure of cardiac myocytes to -ligands was found to affect contractility, Ca2 influx, and beating rate (Ela et al., 1994) and to increase intracellular level of inositol 1,4,5-trisphosphate (IP3) in cultured myocytes (Novakova et al., 1998). -Ligands affect intrasynaptosomal free Ca2 levels in rat forebrain synaptosomes and protein phosphorylation (Brent et al., 1997). Certain -ligands also have been

ABBREVIATIONS: ER, endoplasmic reticulum; IP3, inositol 1,4,5-trisphosphate; NMDA, N-methyl-D-aspartate; NE-100, N,N-dipropyl-2-[4methoxy-3-(2-phenylethoxy)phenyl]-ethylamine monohydrochloride; AS ODN, antisense oligodeoxynucleotide; PS, pregnenolone sulfate; ( )PTZ, ( )-pentazocine; PRE-084; 2-(4-morpholino)ethyl-1-phenylcyclohexane-1-carboxylate hydrochloride; PT, pertussis toxin; BDK, bradykinin; TG, thapsigargin; HBSS, Hanks balanced salt solution; MS ODN, mismatched oligodeoxynucleotide; TBST, Tris-buffered saline/Tween 20; Prog, progesterone; GABA, -aminobutyric acid; T B C, TG BDK caffeine; VDCC, voltage-dependent Ca2 channel. 788

2000

Ca2 Signaling via

-Receptors

789

shown to affect N-methyl-D-aspartate (NMDA)-induced Ca2 signaling in rat primary neurons (Hayashi et al., 1995; Klette et al., 1997). However, none of these studies has definitively demonstrated a clear-cut agonist-antagonist relationship in which pharmacologically relevant concentrations of ligands were used and the antagonists by themselves produced no effect. Furthermore, none of the above-mentioned studies has definitively demonstrated which subtype of -receptors (i.e., 1 or 2; Quirion et al., 1992; Hellewell et al., 1994) mediated these effects. With the availability of a selective 1-receptor antagonist N,N-dipropyl-2-[4-methoxy-3-(2-phenylethoxy)phenyl]-ethylamine monohydrochloride (NE-100) (Okuyama and Nakazato, 1996) and the successful demonstration of the use of an antisense oligodeoxynucleotide (AS ODN) directed against the cloned 1-receptors in a behavioral test (King et al., 1997), we decided to systematically investigate the potential involvement of 1-receptors in Ca2 signaling with laser scanning confocal microscopic examinations in a neuroblastoma glioma cell line (NG108) with two specific purposes. First, we wanted to establish a clear-cut agonist-antagonist relationship within the context of Ca2 signaling for -receptors in a simple biological system; Second, we wanted to establish that the effects, if any, are mediated via 1-receptors. Because Ca2 signaling is regulated mainly by intracellular organelles such as the ER and by Ca2 influxes at the plasma membrane and because -receptors have been shown to exist on both the ER and the plasma membrane (McCann and Su, 1990), this study examined the potential involvement of 1-receptors in Ca2 signaling in both regards: via an intracellular site of action and via the plasma membrane. Three compounds, pregnenolone sulfate (PS), ( )-pentazocine [( )-PTZ], and 2-(4-morpholino)ethyl-1-phenylcyclohexane-1-carboxylate hydrochloride (PRE-084), each representing a 1-ligand of different chemical class, were examined.

Experimental Procedures
Materials. PS, pertussis toxin (PT), MK-801 (dizocilpine), ( )bicuculline, and bradykinin (BDK) were purchased from Research Biochemicals International (Natick, MA). Thapsigargin (TG), Tween 20, phenylmethylsulfonyl fluoride, and aprotinin were from Calbiochem (San Diego, CA). ( )-PTZ was obtained from Research Triangle Institute (Research Triangle Park, NC). [3H]IP3 and the IP3 assay kit were purchased from Amersham (Arlington Heights, IL). All other chemicals were from Sigma Chemical Co. (St. Louis, MO) Confocal Fluorescence Microscopic Examination. NG108 cells were cultured as described before (Hescheler et al., 1987) and maintained on petriPERM with a four-well FlexiPERM (Heraerus Instr., Am Kalkberg, Germany) attached to it. The cultured cells on petriPERM were washed with Hanks balanced salt solution (HBSS) (137 mM NaCl, 0.4 mM MgSO4, 0.5 mM MgCl2, 5.4 mM KCl, 0.4 mM KH2PO4, 0.3 mM Na2HPO4, 3.0 mM NaHCO3, 1.5 mM CaCl2, 5.6 mM glucose, and 20 mM HEPES, pH 7.4) and loaded with 5 M fluo-3/AM (Molecular Probes, Eugene, OR) in HBSS for 25 min at room temperature. Then uniform fluorescence intensities were observed in each cell. Permeabilization of cells with 10 M digitonin in a Ca2 -free medium completely eliminated the fluorescence signals inside the cells, indicating that the observed fluorescence intensities represent free Ca2 in the cytosol (Golovina and Blaustein, 1997). After loading, cells were placed on the microscope stage and perfused continuously (2 ml/min) with HBSS at 37C by using two peristaltic pumps (input and output) to maintain the test well volume at 200 l. One end of the solution input line was attached to a plastic

pipette tip that was placed 1.5 mm above the cells. The other end of the input line was placed into beakers containing HBSS or HBSS with drugs at test concentrations. In the BDK experiments, HBSS containing -ligands was perfused into the well for at least 10 min. Afterward, a solution containing both the -ligands and 1 M BDK was perfused into the well for additional 2 min. In the KCl experiments, the cells were first perfused with the HBSS containing a test drug (such as -ligands) or a combination of several different drugs for 10 min. The same solution with an addition of 75 mM KCl was then applied to the cells for a duration of 30 s before the solution was replaced with the original solution containing only the test ligand(s). In this perfusion system, maximal response to KCl was reached within 3 to 5 s. Dye-loaded cells were perfused with 37C HBSS and the cytosolic free Ca2 concentration ([Ca2 ]cyt) was monitored with a laser scanning confocal system (Zeiss, Oberkochen, Germany) attached to a Zeiss Axiovert 135 inverted microscope. Laser scanning microscopic images were collected every 2 s with a Zeiss 40X achroplan water-immersion objective (0.75 numerical aperture), an argon laser (488 nm) excitation, and a 520-nm-long pass barrier filter. The confocal optical section was 1.5 m in thickness and the optical section of cells was adjusted to show both the cytosol and nucleus on the same section. Images (512 512 pixels) were collected digitally with the Zeiss Image Series software. Regions of interest were selected from the areas between the plasma membrane and nucleus. The nucleus was excluded from the Ca2 measurement because the intranucleosomal Ca2 dynamics might be different from that in the cytosol. [Ca2 ]cyt was calibrated in each cell according to the equation [Ca2 ] Kd[F(t) Fmin]/[Fmax F(t)], as described by Kao et al. (1989), in which F(t) is the measured fluorescence intensity and Kd is the Ca2 -fluo-3 dissociation constant (390 nM). The Fmax equals (FMn Fbkg)/0.2 Fbkg and the Fmin equals (Fmax Fbkg)/40 Fbkg. FMn is the average of fluorescence intensities for 30 s with ionomycin (10 M) and MnCl2 (2 mM), and Fbkg is the average of fluorescence intensities for 30 s with ionomycin (10 M) and MnCl2 (2 mM) after lysis of cells with 40 M digitonin. In this report, each experimental determination used a four-well FlexiPERM plate. An average of only three to nine cells per culture well, but never more than nine cells per well, was examined in each determination, which always included a control well. In each determination, a similar treatment condition was never repeated in other wells except occasionally the controls were repeated. Statistical significance was analyzed by comparing values from all cells receiving the same treatment condition in separate determinations. In this report, the number of determinations in each experimental group is indicated in parentheses after the number of cells examined. AS ODN Transfection. Genes of the 1-receptor were highly conserved from mouse to humans (Hanner et al., 1996; Prasad et al., 1998). Therefore, a 21-mer AS ODN, which was published based on the mouse sequence for 1-receptor (King et al., 1997), was synthesized with the Cyclone Plus DNA synthesizer (Milli Gen/biosearch, Bedford, MA), purified through an NAP-10 column (Pharmacia Biotech, Uppsala, Sweden), and used in this study. The sequences of the AS ODN and the mismatched oligodeoxynucleotide (MS ODN) control with three pairs of nucleotide substitutions were, respectively (King et al., 1997): 5 -GAGTGCCCAGCCACAACCAGG-3 and 5 GAGGTCCCGACCACACACAGG-3 . When NG108 cells reached a 40 to 50% confluency, adherent cells were washed with culture medium containing reduced fetal calf serum (5%) without penicillin and streptomycin. For transfection, cells were treated with 200 l of the same medium containing Lipofectin reagent (Life Technologies, Gaithersburg MD) and the AS ODN or MS ODN at 3.75 g/ml. Cells were incubated at 37C under 10% CO2 for 6 h and then 0.8 ml of Dulbeccos modified Eagles medium with 10% fetal calf serum (without antibiotics) was added to each culture well. Cells were used for experiments 48 to 72 h after the transfection. The culture medium for the transfection experiment contains 0.1 mM hypoxanthine, 400 nM aminopterin, and 16 M thymidine.

790

Hayashi et al.

Vol. 293

Determination of IP3 Concentration. For the determination of contents of IP3, NG108 cells were washed with PBS (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, and 1.4 mM KH2PO4, pH 7.4) and resuspended in HBSS containing 10 mM LiCl at a density of 2 105 cells/ml. Cells (6 104) in 300- l aliquots were preincubated for 10 min at 37C and then stimulated with different concentrations of BDK, in the presence and absence of 100 nM ( )-PTZ, for 15 s. The reaction was terminated by adding 0.2 volumes of ice-cold 20% perchloric acid. The resultant samples were adjusted to pH 7.5 with KOH-HEPES buffer. Neutralized samples were centrifuged to remove KClO4, and the supernatant was used for the IP3 assay in a radioligand method with [3H]IP3 as previously described in Katayama et al. (1994). Immunodetection of 1-Receptors by Western Blotting. A polyclonal antibody was raised in rabbit against a 20-amino acid peptide corresponding to the fragment 143 to 162 (synthesized by Neosystem, Strasbourg, France) of rat 1-receptor. The peptide was conjugated to BSA with glutaraldehyde (1 mg/peptide/5 mg of BSA) and the complex was dialyzed against saline. Three rabbits were subsequently subjected to a standard boost of the complex peptide with Freunds adjuvant. For each rabbit, serum was collected before immunization and every 6 weeks after the third injection. The different sera obtained were screened by immunostaining with forebrain sections obtained from adult rats. The antiserum giving the most intense immunostaining was selected and purified against the antigenic peptide with the HiTrap N-hydroxysuccininide-activated affinity column (Pharamcia Biotech). The immunostaining was reduced by the antigen peptide. NG108 cells were washed and incubated with HBSS for 30 min. Cells were treated with or without 1-ligands. The membrane fractions from NG108 cells and rat hippocampus to be used for Western blotting were prepared as described previously and P1, P2, and P3 fractions were obtained accordingly (Furuichi et al., 1989; Miyawaki et al., 1991). Thirty micrograms of protein was dissolved in SDS gel sample buffer and separated by 12% SDS-polyacrylamide gel electrophoresis. For Western blotting, proteins were transferred to a polyvinylidene difluoride membrane (BioRad, Richmond, CA). The nonspecific sites were blocked with 5% (w/v) nonfat dry milk (Bio-Rad) in Tris-buffered saline/Tween 20 (TBST; 10 mM Tris-HCl, pH 8.0; 150 mM NaCl, and 0.05% Tween 20) at 4C overnight. For immunodetection of 1-receptor, antibody was diluted 2000-fold in TBST containing 2% milk and incubated with membrane at 30C for 2 h. After washing, membranes were incubated with horseradish peroxidase-conjugated goat anti-rabbit IgG (1:3000 dilution; 1 h at room temperature; Amersham) in TBST with 5% milk. The peroxidase activity was revealed by using an enhanced chemiluminescence detection kit (Amersham). Statistical Analyses. ANOVA was first used to check the statistical tendency of experimental data. Differences between groups of data were then examined post hoc by Fishers protected least-significant difference test or Students t test. All data presented represent mean S.E. The significance level was set at P .05.

Results
The first experiment tested the effects of 1-ligands PS, ( )-PTZ, and PRE-084 on the basal level of [Ca2 ]cyt in NG108 cells. These three ligands when tested alone under the concentrations used in this study did not cause any change on the basal [Ca2 ]cyt. We speculated that 1-receptors via which these ligands act may play a modulatory role in the present system. The speculation was not far-fetched. For example, -ligands have been shown to exhibit no or minimal effects by themselves in affecting phosphoinositide turnover whereas were able to modulate carbachol-induced (i.e., stimulated) phosphoinositide turnover in brain synaptoneurosomes (Bowen et al., 1988). Also, consistent with this speculation, in neurophysiological studies, -ligands have

been shown to cause no effects of their own unless compound such as NMDA or neuropeptide Y was added to perturb the system (Monnet et al., 1992). We decided therefore to test the activities of PS, ( )-PTZ, and PRE-084 in systems that might represent a perturbed state of [Ca2 ]cyt and not that of a resting condition. Two systems were chosen. The first examined the effects of these 1-ligands on the BDK-induced increase of [Ca2 ]cyt. The second examined the effects of these ligands on the depolarization-induced increase in [Ca2 ]cyt. We first tested the effects of 1-ligands on the increase of [Ca2 ]cyt induced by BDK. BDK is known to, via BDK receptors, increase [Ca2 ]cyt concentration by increasing the formation of intracellular IP3, which in turn increases the [Ca2 ]cyt via IP3 receptors on the ER (Berridge, 1993; Thomas et al., 1996). In this study, BDK was found to concentration dependently cause a sharp rise in [Ca2 ]cyt in NG108 cells, which subsided within 20 s (Fig. 1, inset). The peak height of [Ca2 ]cyt was used for comparison of effects caused by different ligands in this study. Typically, 1 M BDK increased the [Ca2 ]cyt from a basal level of 78.3 5.4 to 889 84 nM (mean S.E.; n 24 cells). Pretreatment of cells with PT abolished the effect caused by BDK (data not shown). BDK-induced [Ca2 ]cyt response was quantified by subtraction of the resting level from maximal [Ca2 ]cyt elicited by BDK. This effect by BDK is an intracellular event because the removal of Ca2 from the perfusion buffer did not significantly affect the effect caused by BDK (Fig. 1, upper right inset). The Ca2 chelator could not be used in the experiment because the chelator caused cells to detach from culture plates. Also, the TG treatment suppressed the action of BDK. The results are in alignment with the established notion that BDK increases [Ca2 ]cyt by mobilizing Ca2 from intracellular stores (Berridge, 1993). PS (0.1100 M), ( )PTZ (0.00110 M), and PRE-084 (0.0110 M) concentration dependently potentiated the increase of [Ca2 ]cyt caused by BDK in a bell-shaped manner with the peak height at 1, 0.1, and 0.1 M, respectively (Fig. 1). However, it has to be mentioned that these potentiating effects exerted by -ligands can only be seen after a close to 10-min incubation of cells with the -ligands. The 10-min incubation was a minimal effective period. Treatment of cells with 1-ligands for 10 min did not produce a significantly different effect. Progesterone (Prog; 0.00110 M), another -ligand (Su et al., 1988), also was tested. Prog at 1 M tended to potentiate the BDK effect. However, this effect of Prog was not statistically significant. Prog at 10 M tended to decrease the BDK effect (Fig. 1, right). A selective 1-antagonist NE-100 (0.0011 M) by itself produced no effect on that caused by BDK (Fig. 1, right). The potentiating action of PS on the BDK-induced increase in [Ca2 ]cyt was not affected by either the NMDA receptor channel blocker MK-801 or the -aminobutyric acid (GABA)A receptor antagonist ( )-bicuculline (Fig. 2a), but was antagonized by a selective 1-receptor antagonist NE-100 (1 M; Fig. 2a). NG108 cells have been shown to contain NMDA receptors (Ohkuma et al., 1994) as well as GABAA receptors (Yoshii et al., 1997). These results indicate that PS potentiated the [Ca2 ]cyt increase induced by BDK via 1-receptors and not via NMDA or GABAA receptor. It was noted that MK-801 slightly enhanced, but not to a statistically significant level, the BDK-induced [Ca2 ]cyt increase either in the absence or presence of PS (Fig. 2a). No report in the litera-

2000

Ca2 Signaling via

-Receptors

791

Fig. 1. Potentiation of BDK-induced increase in [Ca2 ]cyt in NG108 cells by PS and other nonsteroidal 1-receptor ligands ( )-PTZ and PRE-084 (PRE). An average of three to nine cells from each culture well were examined per determination. Data represent mean S.E. of values from all cells receiving the same treatment in multiple determinations (see Experimental Procedures for details). The number of determinations per experimental group is indicated in parentheses after the cell numbers in this report. Representative traces of the BDK-induced increase in [Ca2 ]cyt in the presence [PS( ); 1 M] and absence [PS( )] of PS are shown in the inset. The other curves represent the effects of -ligands in potentiating the BDK-induced increase in [Ca2 ]cyt. Data are based on a 10-min pretreatment time of cells with PS [n 37 62 cells (8 10 per dose)], ( )-PTZ [n 3174 cells (712 per dose)], PRE-084 [n 291 cells (6 14 per dose)], progesterone [Prog; n 20 36 cells (57 per dose)], and NE-100 [n 23 46 cells (5 8 per dose)]. One-way ANOVA was used to analyze each curve. Fishers protected least-significant difference test was used post hoc to examine differences between groups of data. *P .05, **P .01 compared with BDK alone without the -ligands. Upper right inset, removal of Ca2 from perfusion medium did not significantly affect the BDK-induced increase in [Ca2 ]cyt [n 51 and 39 cells (9 and 6), respectively, with and without Ca2 ; P .1989].

ture has shown that MK-801 enhances the action of BDK. The exact reason for this action of MK-801, if any, is unknown at present. Because Prog has been shown to be an antagonist against ( )-PTZ-induced improvement of learning and memory in animal models of amnesia (Maurice et al., 1998), Prog was tested against the ( )-PTZ potentiation of BDK-induced increase in [Ca2 ]cyt. Similar to the results shown in Fig. 1, 1 M Prog by itself slightly caused an increase of the BDK effect (Fig. 2b, center). Nevertheless, in the presence of 1 M Prog, the ( )-PTZ potentiation of BDKinduced increase in [Ca2 ]cyt was no longer significantly different from controls (Fig. 2b, center). These results suggest that Prog is acting as an antagonist in this study, being able to block the action of a -agonist ( )-PTZ. The 1-receptor antagonist NE-100, although without effect by itself, was found to significantly block the PRE-084 potentiation of BDK-induced increase in [Ca2 ]cyt (Fig. 2b, right). To further substantiate that the effect by 1-ligands in potentiating the BDK-induced increase in [Ca2 ]cyt is mediated via 1-receptors, a 21-mer AS ODN-directed against the cloned 1-receptors from mouse brain according to a published result (King et al., 1997) was used to test against PS and ( )-PTZ in this study. The transfection of cells with AS ODN completely abolished the PS and ( )-PTZ potentiation on the BDK-induced increase in [Ca2 ]cyt (Fig. 2c). However,

a mismatch MS ODN control with three pairs of deoxynucleotide bases switched (King et al., 1997) did not affect the effect of PS and ( )-PTZ (Fig. 2c). Removal of Ca2 from perfusion buffer did not affect the potentiating action of ( )-PTZ on the BDK-induced increase in [Ca2 ]cyt (data not shown). This indicates that 1-ligands potentiate the BDK-induced increase of [Ca2 ]cyt through an intracellular site of action. Because BDK is known to increase [Ca2 ]cyt by increasing the formation of intracellular IP3, we examined whether the intracellular site of action exerted by 1-ligands might be related to their ability to potentiate the formation of IP3 induced by BDK. Therefore, IP3 concentrations were measured. In the absence of BDK, ( )-PTZ (100 nM) did not alter the basal concentration of IP3 over the observation period of 10 min (Fig. 3a). BDK, as expected, increased the IP3 formation in a concentrationdependent manner (Fig. 3b). ( )-PTZ (100 nM) did not significantly affect the potency of BDK in increasing the IP3 formation (Fig. 3b). ( )-PTZ, however, attenuated the maximal ceiling effect exerted by BDK in IP3 formation (Fig. 3b). These results suggest that 1-ligands affect BDK-induced [Ca2 ]cyt intracellularly at a locus beyond the IP3 formation. Because IP3 increases [Ca2 ]cyt by acting on the IP3 receptors on the ER where 1-receptors are abundant, it is possible that 1-ligands may affect [Ca2 ]cyt by potentiating the ac-

792

Hayashi et al.

Vol. 293

Fig. 2.. Antagonism of the potentiating effect of -ligands on BDK-induced increase in [Ca2 ]cyt by various drugs or ODNs directed against M) by MK-801 (10 M), ( )-bicuculline (100 M), and NE-100 (1 M) [n 40 55 cells (6 8) per group]. BDK was 1-receptors. a, effect of PS (1 present in all experiments. Students t test was used to examine differences between each control (i.e., BDK antagonist alone) and the antagonist-treated (i.e., BDK antagonist PS) group. *P .05 compared with respective controls. b, effects of ( )-PTZ (100 nM) and PRE-084 (100 nM) by NE-100 [1 M; n 48 55 cells (6 8) against ( )-PTZ; n 34 66 cells (57) against PRE] and Prog [1 M; n 28 33 cells (5 6) against

2000

Ca2 Signaling via

-Receptors

793

Fig. 3.. Effects of -ligand ( )-PTZ on IP3 formation in the absence and presence of BDK. a, effect of ( )-PTZ in the absence of BDK. NG108 cells were incubated in HBSS with (F) and without (E)100 nM ( )-PTZ for 0, 0.5, 2, 5, and 10 min. IP3 formation per 104 cells was measured as described in Experimental Procedures. Each value represents mean of six to eight separate experiments. No statistical difference was found between all time points. b, effect of ( )-PTZ in the presence of BDK. NG108 cells were stimulated for 30 s with increasing concentrations of BDK in the presence (F) or absence (E) of 100 nM ( )-PTZ. Each value represents the mean from six separate experiments. Students t test was used to compare the differences. *P .05, **P .01 compared with the values elicited by the same concentration of BDK in the absence of ( )-PTZ.

tion of IP3 on the ER via an as-yet-unknown mechanism. These results also suggest that the descending phase of the bell-shaped dose-response curves seen in Fig. 1 may be due to the 1-ligand suppressing the IP3 formation at high doses. As mentioned in the Introduction, -receptors are known to exist not only on the ER but also on the plasma membrane with the latter containing less -receptors (McCann and Su, 1990). As such, we examined whether 1-receptors might regulate the [Ca2 ]cyt increase caused by KCl-induced depolarization in NG108 cells. However, to examine any potential action of 1-receptors on the plasma membrane, it was necessary to eliminate [Ca2 ]cyt changes attributable to the intracellular sites of action caused by 1-ligands. KCl (75 mM) induced depolarization in NG108 cells. The components of the apparent increase of [Ca2 ]cyt caused by the KCl-induced depolarization were characterized. KCl (75 mM) evoked an initial transient increase in [Ca2 ]cyt, appearing as an apparent peak height, followed by a declined phase that subsided when KCl was withdrawn. Typically, KCl (75 mM) increased [Ca2 ]cyt from an average peak height of 72.3 5.6 to 292.8 11.1 nM (n 42 cells from nine determinations). In the absence of extracellular Ca2 , KCl-induced increase in [Ca2 ]cyt was almost totally diminished (11.4 2.2%; n 13 cells from three determinations) compared with controls with normal extracellar Ca2 in the perfusion buffer (Fig. 4, filled columns). Nifedipine, an L-type Ca2 channel blocker, dose dependently inhibited the KCl-induced increase in [Ca2 ]cyt. Nifedipine at 100 nM attenuated the KCl-induced increase in [Ca2 ]cyt to only 15.1 4.2% of that induced by 75 mM KCl without nifedipine (n 10 cells from three determinations; Fig. 4, filled columns). The IC50 of nifedipine in inhibiting the KCl-induced effect was 25 nM. These results indicate that the 75 mM KCl-induced increase of [Ca2 ]cyt involved the voltage-dependent L-type Ca2 channel (VDCC). Because the

apparent increase of [Ca2 ]cyt induced by KCl depolarization also might involve certain components attributable from mobilization of Ca2 from intracellular Ca2 stores, including the Ca2 -induced Ca2 release (Berridge, 1993; Thomas et al., 1996), we examined the effects of compounds that are known to affect intracellular Ca2 mobilization in the KCltreated cells. The pretreatment of cells for 10 min with TG (1 M), an inhibitor of Ca2 -ATPase on the ER (Gill et al., 1996), attenuated the KCl-induced increase in [Ca2 ]cyt (to 62.0 2.7% of control; n 12 cells from three determinations; Fig. 4, unfilled columns). BDK (300 nM) did not affect the KCl-induced [Ca2 ]cyt if administered alone to cells for 10 min before the KCl challenge. However, administration to cells with a combination of BDK (300 nM) plus TG (1 M) for 10 min could further attenuate the KCl-induced increase in [Ca2 ]cyt compared with TG pretreatment alone (to 49.4 2.7% of controls; n 12 cells from three determinations; Fig. 4, unfilled columns). Similarly, the addition of caffeine (3 mM), a ryanodine receptor agonist (Gill et al., 1996), to the pretreatment solution containing TG and BDK also caused a further attenuation of KCl-induced increase in [Ca2 ]cyt compared with the TG pretreatment alone (to 39.3 1.9% of controls; n 12 cells from three determinations; Fig. 4, unfilled columns). These data, when taken together with the above-mentioned results with nifedipine, indicate that the 39% of KCl-induced increase in [Ca2 ]cyt in NG108 cells apparently arouse from Ca2 influx across the plasma membrane via VDCC, and the rest of the 61% came from Ca2 releases from intracellular stores as a result of the Ca2 influx at the plasma membrane, including Ca2 -induced Ca2 release (Berridge, 1993; Thomas et al., 1996). It has to be mentioned herein that caffeine was found in a report to cause an influx of Ca2 from the extracellular space that lasted for at least 3 min when tested in TG-pretreated DDT1

( )-PTZ] treatments. Data from each group (i.e., per four columns) was analyzed by one-way ANOVA followed by Fishers protected least-significant difference test. Each group has its own control ( ). *P .05, **P .01 compared with controls. c, effects of PS and ( )-PTZ by antisense (AS) ODN directed against 1-receptors. See Experimental Procedures for ODN transfection. Forty-eight hours after the transfection, cells were subjected to experiments. MS ODN was used in the experiment for comparison [n 29 39 cells (57) per group]. Students t test was used to compare differences between each column and the control ( ). *P .05, **P .01 compared with control.

794

Hayashi et al.

Vol. 293

Fig. 4.. Characterization of KCl-induced [Ca2 ]cyt increase in NG108 cells (f) and the effects of TG, BDK, and caffeine treatment (E). Control cells received Ca2 in perfusion buffer. The peak height of KCl (75 mM)-induced increase in [Ca2 ]cyt in control cells were taken as 100%. In the Ca2 store depletion studies ( ), TG, BDK, and caffeine (Caf) were used to pretreat the cells. See text for details of results, cell numbers, and numbers of determinations for all experimental groups. Values are normalized means S.E. with the control value as 100%. **P .01 compared with ## controls; P .01 compared with TG treatment.

MF-2 cells (Gill et al., 1996). However, in the present study, we found that, during the 10-min pretreatment with a combination of TG plus caffeine, the overall [Ca2 ]cyt profile was the same as that with TG pretreatment alone, except that an initial transient rise in [Ca2 ]cyt was observed that was attributable to caffeine. This suggests an absence of caffeineinduced Ca2 influx similar to that reported by Gill et al. (1996) in TG-pretreated NG108 cells. The reason for the discrepancy is unknown at present. Nevertheless, collectively, our results indicate that to study the potential role of 2 influx across the 1-receptors on the modulation of Ca plasma membrane, a cocktail of 1 M TG, 300 nM BDK, and 3 mM caffeine for a duration of time (10 min) can be used to nearly deplete the ER Ca2 stores, leaving the majority of [Ca2 ]cyt, reflecting an increase sequel to a Ca2 influx from the extracellular space. Cells were thus treated with a cocktail containing 1 M TG, 300 nM BDK, and 3 mM caffeine before use. The combination of the three drugs is abbreviated as T B C and used in the following studies to ensure that the effects seen with 1-ligands were mediated via an action on the plasma membrane. After the treatment of T B C, 75 mM KCl caused a depolarization in NG108 cells and an increase in [Ca2 ]cyt. Again, under the basal condition (i.e., without KCl) in the presence of T B C, PS, ( )-PTZ, and PRE-084 caused no effect of their own. However, PS and ( )-PTZ concentration dependently inhibited the KCl-induced increase in [Ca2 ]cyt, whereas PRE-084 potentiated the KCl-induced increase in [Ca2 ]cyt (Fig. 5a). Similar to the BDK studies presented earlier, it required a 10-min incubation of cells with the -ligands to see these effects caused by the ligands. However, unlike the BDK studies (Fig. 1), the dose-response curves seen herein are regular and not bell shaped. These results, when taken together with results obtained in Fig. 3, suggest an absence of the involvement of IP3 receptors in the effects of -ligands in affecting the depolarization-induced Ca2 influx at the plasma membrane. The 21-mer AS ODN (King et al., 1997) and the corresponding MS ODN (King et al., 1997) designed to act against cloned 1-receptors were again used to examine whether these effects caused by 1-ligands, albeit being inhibitory or

potentiating, were mediated by 1-receptors. The AS ODN treatment significantly blocked both the inhibitory effect caused by ( )-PTZ (Fig. 5b) and the potentiating effect caused by PRE-084 (Fig. 5b; ANOVA and Students t tests). For the action of PS, the AS ODN treatment, although it did not significantly block the effect produced by PS when data were compared at each individual test dose of PS (Students t test; Fig. 5b), could however significantly abolish the overall dose-dependent effect caused by PS (ANOVA). Thus, PS produced no significant overall effect when cells were pretreated with AS ODN (Fig. 5b). The MS ODN has no effect at all on all these actions caused by 1-ligands (Fig. 5b). Because the action of -receptors have been suggested to be related to G protein (Monnet et al., 1992, 1994), we examined if these actions by 1-ligands on the plasma membrane in this study are sensitive to PT treatment. Results showed that PT treatment totally abolished the inhibitory action caused by ( )-PTZ. The potentiating effect caused by PRE084 on the depolarization-induced increase of [Ca2 ]cyt was diminished to a nonsignificant level (Fig. 6; see legend). Immunoblotting analyses with the polyclonal antibodies raised against fragment 143 to 162 of rat 1-receptors demonstrated a single band with molecular mass of 30 kDa in the P3 subcellular fractions prepared from either NG108 cells or the Sprague-Dawley rat hippocampus (Fig. 7a). The molecular mass of the immunoreactive peptide is close to that of the cloned 1-receptor (Hanner et al., 1996). In NG108 cells without an incubation with 1-ligand, the immunoreactive 1receptors were predominantly present in microsomes (P3), barely detectable in the plasma membrane (P2) and the nuclear membrane (P1), and not detectable in the cytosol (Fig. 7b, top). However, when the NG108 cells were treated with ( )-PTZ (100 nM) for 10 min, relative intensity of immunoreactive 1-receptors increased both in the plasma membrane and the nuclear membrane (Fig. 7b, bottom). Treatment of NG108 cells with the 21 mer AS ODN directed against the cloned 1-receptor for 24 h attenuated the level of immunoreactive 1-receptors (Fig. 7c; AS1). Forty-eight hours after the AS ODN treatment, the level of 1-receptors was significantly reduced (Fig. 7c; AS2). The MS ODN did not affect the level of 1-receptors (Fig. 7c; MS).

2000

Ca2 Signaling via

-Receptors

795

Fig. 5. Effects of PS and nonsteroidal -receptor ligands ( )-PTZ and PRE-084 on the depolarization (75 mM KCl)-induced increase in [Ca2 ]cyt when NG108 cells were depleted of intracellular endoplasmic reticulum Ca2 stores by T B C (see Experimental Procedures). a, representative traces of KCl-induced increase in [Ca2 ]cyt in the absence and presence of PS (1 M) and the dose-response curves of PS, ( )-PTZ, and PRE-084 [n 39 52 cells (6 9) at each dose]. Each curve was analyzed by one-way ANOVA followed by Fishers protected least-significant difference test as a post hoc test. *P .05, **P .01 compared with each respective control. b, results of the 1-receptor AS ODN and MS ODN treatments on the respective effects caused by PS, ( )-PTZ, and PRE-084 [n 26 47 (5 8) per dose per group]. See Experimental Procedures for details of ODN transfection. Forty-eight hours after the transfection, cells were subjected to experiments. Each curve was analyzed by one-way ANOVA followed by Fishers protected least-significant difference test as a post hoc test for examining statistical differences within a curve. The difference between two data points of different curves, at the same concentration of test drug, was analyzed by Students t test. ANOVA indicates that in the presence of AS ODN, all drugs produced no effect [ANOVA: P .90 for PS, P .59 for ( )-PTZ, P .52 for PRE-084]. *P .05, **P .01 compared with controls; #P .05, ##P .01 between cells receiving AS ODN and MS ODN in the presence of the same dose of -ligands.

Discussion
We have clearly demonstrated that, in nanomolar concentrations, the endogenous neurosteroid PS and the other -ligands ( )-PTZ and PRE-084 can modulate Ca2 signaling via 1-receptors in two different modes of action: one an intracellular action perhaps on the ER, and the other on the plasma membrane via a G-protein-dependent action. 1-Receptors may thus represent a newly recognized, unique onetransmembrane protein regulating Ca2 signaling in cells. This study constitutes the first report demonstrating a clearcut agonist-antagonist relationship for 1-receptors with ligands being effective in nanomolar concentrations and antagonist showing no effect of its own in a simple biological system such as an established cell line. Our results with PS also represent the first direct demonstration that endogenous

neurosteroids can affect Ca2 signaling via the newly recognized 1-receptor system in cells. Our results showing that the potentiating effects of 1ligands on the BDK-induced increase in [Ca2 ]cyt was not affected by the removal of Ca2 from perfusion medium suggest that the loci of the action of these ligands are intracellular and are perhaps on the ER because 1-receptors are ER proteins and the BDK effect was blocked by the AS ODN against 1-receptors. Further substantiating this notion is our results showing that the IP3 concentration was not increased by -ligand. In fact, the -ligand tended to decrease the efficacy of the BDK-induced increase of IP3 formation (Fig. 3). These results are in contrast to the report that showed that -ligands increased the basal level of IP3 in cultured myocytes (Novakova et al., 1998). The discrepancy

796

Hayashi et al.

Vol. 293

Fig. 6. Effect of PT pretreatment on the modulation of depolarizationinduced [Ca2 ]cyt increase by -ligands in NG108 cells that were depleted of ER Ca2 stores. Depletion of ER Ca2 stores was achieved by using T B C (see Experimental Procedures). Cells were treated with 50 ng/ml PT in culture medium for 18 h before experiments. KCl (75 mM) was used to induce depolarization [n 40 45 cells (6 8) at each dose of test drug]. Each curve was analyzed by one-way ANOVA followed by Fishers protected least-significant difference test as a post hoc test for examining statistical differences within a curve. The difference between two data points of different curves, at the same concentration of test drug, was analyzed by Students t test. *P .05, **P 0.01 compared with controls. The overall PRE-084 effect and ( )-PTZ effect were not significant in the presence of PT (ANOVA: P .25 and P .79, respectively). ##P .01 between cells with PT [PT( )] and without PT treatment [PT( )].

may have been caused by different cell types (cardiac versus neuroglial) used in the two studies. Our results showing that 1-receptors mediate both the inhibitory action of PS and ( )-PTZ and the potentiating action of PRE-084 in affecting the depolarization-induced changes in [Ca2 ]cyt at the plasma membrane are difficult to explain from a molecular perspective. All these effects, albeit being different in direction, are however mediated via 1 because the effects were abolished by the AS ODN directed against cloned 1-receptors. A speculation would be that these opposite effects might be attributable to subtypes of 1-receptors that happen to share the same amino acids encoded by the 21 ODN. More experiments are needed to totally clarify these observations. The exact relationship between 1-receptors and the PTsensitive G protein (Gi or Go) is unclear at present. Because almost all G-protein-associated receptors contain seven transmembrane regions, we speculate that 1-receptors may not be directly linked to Gi or Go, but might be associated with these G proteins via an indirect mechanism. VDCCs are regulated by G proteins (De Waard et al., 1997). Whether 1-receptors act via the VDCC-related G protein is unknown at present. Our results on the immunoreactive 1-receptors are intriguing. It is interesting to note that in control NG108 cells without the presence of exogenously applied 1-ligands, 1receptors are predominantly present in the microsomes (P3; Fig. 7b, top). 1-Receptors are slightly detectable in the plasma membrane (P2) and the nuclear membranes (P1). However, in the presence of 1 ligand [( )-PTZ; Fig. 7b, top], the relative levels of 1-receptors in the plasma membrane and the nuclear membrane are increased (Fig. 7b, bottom). These results are consistent with a recent report (MorinSurun et al., 1999) and suggest that 1-receptors are translocated to the plasma membrane and nuclear membrane in the presence of 1-ligand. These data may thus explain why an intracellular ER protein such as the 1-receptor can affect

Fig. 7.. Western blotting of 1-receptors: effects of the -ligand treatment and the AS ODN treatment. The antibody was raised by using the 143 to 162 peptide fragment of rat 1-receptors as the antigen (see Experimental Procedures). a, protein extracts from NG108 cells and rat hippocampus were prepared as described in Experimental Procedures. Thirty micrograms of P3 proteins from both NG108 cells and the rat hippocampus was used in this experiment. The immunoblots were performed with 1:2000 dilution of anti- 1-antibody. Hip, rat hippocampus. Numbers on the right side are molecular masses of protein standards. b, effect of ( )-PTZ. NG108 cells were treated with ( )-PTZ (100 nM) for 10 min. Thereafter the cytosol and P1, P2, and P3 subcellular fractions were prepared and analyzed with Western blotting. Control cells received no ( )-PTZ. P3 proteins from rat hippocampus also were included for comparison (hip). Note the increase of relative intensity of immunoreactive 1-receptors in the P1 and P2 fractions after ( )-PTZ treatment (bottom). c, effects of AS ODN and MS ODN treatments on the level of immunoreactive 1-receptors. See Experimental Procedures for details of ODN transfection. Thirty micrograms of P3 fraction from NG108 cells was electrophoresed on each lane. AS1, 24 h after transfection; AS2, 48 h after transfection; and MS, 48 h after transfection. AS ODN and MS ODN were dissolved in minimal amount of H2O before use. Control cells received only H2O.

Ca2 signaling at the plasma membrane. To our knowledge, this is the first report suggesting that a Ca2 signalingaffecting protein can be translocated from the ER to the plasma membrane. Thus, by extension, the endogenous 1ligand such as PS may play an important role in the translocation of 1-receptors. Because ( )-PTZ is a relatively well known 1-ligand (Quirion et al., 1992; Hellewell et al., 1994), we examined in this study only the effect of ( )-PTZ on 1-receptor translocation. Effects of other 1-ligands such as PRE and PS will be examined in future experiments. The effective concentration of PS used in this study (1 M) is close to the Kd value of PS at the -receptors (3 M). This concentration of PS may raise a question whether the effect of PS seen in this study is physiologically relevant. The basal concentration of PS in rat brain hippocampus is typically 12 ng/g (Vallee et al., 1997). However, in different regions of the brain, neurosteroid concentrations may vary according to environmental and behavioral circumstances, such as stress, sex recognition, and aggressiveness (Baulieu, 1998). It remains to be determined whether PS concentration can be raised, at least locally, in the brain to a low micromolar concentration that might affect Ca2 signaling via 1-recep-

2000

Ca2 Signaling via

References

-Receptors

797

tors. A progesterone-binding protein with certain similarity, but not totally the same as 1-receptors, has been identified in porcine liver and was suggested to be a member of the 1-receptor superfamily with a progesterone specificity (Falkenstein et al., 1998). However, the sequence of the protein does not resemble 1-receptors except that they both possess only one transmembrane region. There are reports showing that 2-receptors also exist in NG108 cells (Georg and Friedl, 1991). However, our results with the AS ODN directed against cloned 1-receptors suggest that 1-receptors are the receptor responsible for affecting Ca2 signaling observed in the present study. It is interesting to note that in a meeting report examining another cell line, Bowen et al. (1996) has suggested that certain -ligands may modulate intracellular Ca2 levels via 2-receptors. Unfortunately, 2-receptors have not been cloned. A definitive answer concerning role of 2-receptors in Ca2 signaling may arise when the sequence of 2-receptors becomes available. Our results showing the modulation of depolarization-induced Ca2 influx by 1-ligands suggest that 1-receptors modulate VDCC. Klette et al. (1997) reported that -ligands inhibited KCl-induced [Ca2 ]i increases in primary cultured neurons. However, the effective concentrations of -ligands in that study are typically in the medium to high micromolar ranges and no agonist-antagonist relations were observed. It is not known whether 1-receptors mediate the effects described by Klette et al. (1997). It has been reported that the 1-receptor shares some pharmacological similarities with the phenylalkylamine Ca2 antagonist emopamil-binding protein (Moebius et al., 1993). The sequences of these two proteins, however, are different. Our present results showing that a 10-min preincubation of cells with -ligands was required to see an effect are in a way in resonance with previous reports demonstrating that at least a 10-min incubation of tissue with -ligands is required to see the resultant protein phosphorylation (Brent et al., 1997) or PI turnover (Bowen et al., 1988). Furthermore, it is interesting but also puzzling to note that in this study, the 10-min preincubation of cells with -ligands as a requirement to see an effect was observed both in the intracellular studies involving BDK and in the plasma membrane studies involving KCl-induced depolarization. Although the translocation of 1-receptors from the ER to the plasma membrane (Fig. 7) may explain the 10-min delay seen with the depolarization experiment, the translocation cannot explain the BDK results. The exact reason for the required 10-min incubation to detect these effects is thus unknown at present. The delayed time course of action may reflect an as yet-to-be investigated biochemical nature of 1-receptors. In conclusion, because 1-receptors are widely distributed in the nervous, endocrine, peripheral, and immune systems (Su, 1991; Hanner et al., 1996), our results demonstrating the modulatory action of 1-receptors on intracellular Ca2 concentration suggest that 1-receptors may play a wide spectrum of physiological roles by acting as a unique, onetransmembrane protein affecting Ca2 signaling in cells.

Acknowledgments

We thank Dr. G. Alonso and M. Anoal (Institut National de la Sante et de la Recherche Medicale U.336) for antibody preparation and purification.

Baulieu EE (1998) Neurosteroids: A novel function of the brain. Psychoneuroendocrinology 23:963987. Berridge MJ (1993) Inositol trisphosphate and calcium signaling. Nature (Lond) 361:315325. Bouchard P, Maurice T, St-Pierre S, Privat A and Quirion R (1997) Neuropeptide Y and the calcitonin gene-related peptide attenuate learning impairments induced by MK-801 via a sigma receptor-mediated mechanism. Eur J Neurosci 9:2142 2151. Bowen WD, Kirschner BN,Newman AH and Rice KC (1988) Sigma receptors negatively modulate agonist-induced phosphoinositide metabolism in rat brain. Eur J Pharmacol 149:399 400. Bowen WD, Vilner BJ, Bandarage UK and Kuehne ME (1996) Ibogaine and ibogamine modulate intracellular calcium levels via interaction with sigma-2 receptors. Soc Neurosci Abstr 22:2006. Brent PJ, Herd L, Saunders H, Sim ATR and Dunkley PR (1997) Protein phosphorylation and calcium uptake into rat forebrain synaptosomes: Modulation by the sigma ligand, 1,3-ditolylguanidine. J Neurochem 68:22012211. Chien C-C and Pasternak GW (1994) Selective antagonism of opioid analgesia by a sigma system. J Pharmacol Exp Ther 271:15831590. De Waard M, Liu H, Walker D, Scott VE, Gurnett CA and Campbell KP (1997) Direct binding of G-protein betagamma complex to voltage-dependent calcium channels. Nature (Lond) 85:148 154. Ela C, Barg J, Vogel Z, Hasin Y and Eilam Y (1994) Sigma receptor ligands modulate contractility, Ca2 influx and beating rate in cultured cardiac myocytes. J Pharmacol Exp Ther 269:1300 1309. Falkenstein E, Schmieding K, Lange A, Meyer C, Gerdes D, Welsch U and Wehling M (1998) Localization of a putative progesterone membrane binding protein in porcine hepatocytes. Cell Mol Biol 44:571578. Furuichi T, Yoshikawa S, Miyawaki A, Wada K, Maeda N and Mikoshiba K (1989) Primary structure and functional expression of the inositol 1,4,5-trisphosphatebinding protein P400. Nature (Lond) 342:3238. Georg A and Friedl A (1991) Identification and characterization of two sigma-like binding sites in the mouse neuroblastoma x rat glioma hybrid cell line. J Pharmacol Exp Ther 259:479 483. Gill DL, Waldron RT, Rys-Sikora KE, Ufret-Vincenty CA, Graber MN, Favre CJ and Alfonso A (1996) Calcium pools, calcium entry, and cell growth. Biosci Rep 16: 139 157. Golovina VA and Blaustein MP (1997) Spatially and functionally distinct Ca2 stores in sarcoplasmic and endoplasmic reticulum. Science (Wash DC) 275:16431648. Hanner M, Moebius FF, Flandorfer A, Knaus H-G, Striessnig J, Kempner E and Glossmann H (1996) Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci USA 93:8072 8077. Hayashi T, Kagaya A, Takebayashi M, Shimizu M, Uchitomi Y, Motohashi N and Yamawaki S (1995) Modulation by sigma ligands of intracellular free Ca2 mobilization by N-methyl-D-aspartate in primary culture of rat frontal cortical neurons. J Pharmacol Exp Ther 275:207214. Hellewell SB, Bruce A, Feinstein G, Orringer J, William W and Bowen WD (1994) Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: Characterization by ligand binding and photoaffinity labeling. Eur J Pharmacol 268:9 18. Hescheler J, Rosenthal W, Trautwein W and Schultz G (1987) The GTP-binding protein, Go, regulates neuronal calcium channels. Nature (Lond) 325:445 447. Kao JP, Harootunian AT and Tsien RY (1989) Photochemically generated cytosolic calcium pulses and their detection by fluo-3. J Biol Chem 264:8179 8184. Katayama S, Shuntoh H, Matsuyama S and Tanaka C (1994) Effect of heat shock on intracellular calcium mobilization in neuroblastoma x glioma hybrid cells. J Neurochem 62:22922299. King M, Pan YX, Mei J, Chang A, Xu J and Pasternak GW (1997) Enhanced kappa-opioid receptor-mediated analgesia by antisense targeting the sigma1 receptor. Eur J Pharmacol 331:R5R6. Klette KL, Lin Y, Clapp LE, DeCoster MA, Moreton JE and Tortella FC (1997) Neuroprotective sigma ligands attenuate NMDA and trans-ACPD-induced calcium signaling in rat primary neurons. Brain Res 756:231240. Martin WR, Eades CE, Thompson JA, Huppler RE and Gilbert PE (1976) The effects of morphine and nalorphine-like drugs in the non-dependent and morphinedependent chronic spinal dog. J Pharmacol Exp Ther 197:517532. Maurice T, Su T-P, Parish DW, Nabeshima T and Privat A (1994) PRE-084, a selective PCP derivative, attenuates MK-801-induced impairment of learning in mice. Pharmacol Biochem Behav 49:859 869. Maurice T, Su T-P and Privat A (1998) Sigma1 ( 1) receptor agonists and neurosteroids attenuate 2535-amyloid peptide-induced amnesia in mice through a common mechanism. Neuroscience 83:413 428. McCann DJ and Su T-P (1990) Haloperidol-sensitive ( )[3H]SKF-10,047 binding sites (sigma sites) exhibit a unique distribution in rat brain subcellular fractions. Eur J Pharmacol 188:211218. Miyawaki A, Furuichi T, Ryou Y, Yoshikawa S, Nakagawa T, Saitoh T and Mikoshiba K (1991) Structure-function relationships of the mouse inositol 1,4,5trisphosphate receptor. Proc Natl Acad Sci USA 88:4911 4915. Moebius FF, Burrows GG, Hanner M, Schmid E, Striessnig J and Glossmann H (1993) Identification of a 27-kDa high affinity phenylalkylamine-binding polypeptide as the sigma1 binding site by photoaffinity labeling and ligand-directed antibodies. Mol Pharmacol 44:966 971. Monnet FP, Debonnel G, Bergeron R, Gronier B and De Montigny C (1994) The effects of sigma ligands and of neuropeptide Y on N-methyl-D-aspartate-induced neuronal activation of CA3 dorsal hippocampus neurons are differentially affected by pertussis toxin. Br J Pharmacol 112:709 715. Monnet FP, Debonnel G and De Montigny C (1992) In vivo electrophysiological evidence for a selective modulation of N-methyl-D-aspartate-induced neuronal

798

Hayashi et al.

Vol. 293
Snyder SH and Largent BL (1989) Receptor mechanisms in antipsychotic drug action: focus on sigma receptors. J Neuropsychiatry 1:715. Su T-P, London ED and Jaffe JH (1988) Steroid binding at receptors suggest a link between endocrine, nervous, and immune systems. Science (Wash DC) 240:219 221. Su T-P (1991) Sigma receptors: Putative links between nervous, endocrine and immune systems. Eur J Biochem 200:633 642. Thomas AP, Bird GS, Hajnoczky G, Robb-Gaspers LD and Putney JW Jr (1996) Spatial and temporal aspects of cellular calcium signaling. FASEB J 10:1505 1517. Vallee M, Mayo W, Darnaudery M, Corpechot C, Young J, Koehl M, Le Moal M, Baulieu E-E, Robel P and Simon H (1997) Neurosteroids: Deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus. Proc Natl Acad Sci USA 94:1486514870. Yoshii M, Watabe S, Sakurai T and Shiotani T (1997) Cellular mechanisms underlying cognition-enhancing actions of nefiracetam (DM-9384). Behav Brain Res 83:185188.

activation in rat CA3 dorsal hippocampus by sigma ligands. J Pharmacol Exp Ther 261:123130. Morin-Surun MP, Collin T, Denavit-Saubie M, Baulieu E-E and Monnet FP (1999) Intracellular 1 receptor modulates phospholipase C and protein kinase C activation in the brainstem. Proc Natl Acad Sci USA 96:8196 8199. Novakova M, Ela C, Bowen WD, Hasin Y and Eilam Y (1998) Highly selective sigma receptor ligands elevates inositol 1,4,5-trisphosphate production in rat cardiac myocytes. Eur J Pharmacol 353:315327. Ohkuma S, Katsura M, Chen D-Z, Chen S-H and Kuriyama K (1994) Presence of N-methyl-D-aspartate (NMDA) receptors in neuroblastoma x glioma hybrid NG108-15 cells - Analysis using [45Ca2 ]influx and [3H]MK-801 binding as functional measures. Mol Brain Res 22:166 172. Okuyama S and Nakazato A (1996) NE-100: A novel sigma receptor antagonist. Cent Nerve Syst Drug Rev 2:226 237. Prasad PD, Li HW, Fei Y-J, Ganapathy ME, Fujita T, Plumley LH, Yang-Feng TL, Leibach FH and Ganapathy V (1998) Exon-intron structure, analysis of promoter region, and chromosomal localization of the human type 1 receptor gene. J Neurochem 70:443 451. Quirion R, Bowen WD, Itzhak Y, Junien JL, Mussachio JM, Rothman RB, Su T-P, Tam SW and Taylor DP (1992) A proposal for the classification of sigma binding sites. Trends Pharmacol Sci 13:85 86. Silve S, Dupuy PH, Labit-Lebouteiller C, Kaghad M, Chalon P, Rahier A, Taton M, Lupker J, Shire D and Loison G (1996) Emopamil-binding protein, a mammalian protein that binds a series of structurally diverse neuroprotective agents, exhibits delta8-delta7 sterol isomerase activity in yeast. J Biol Chem 271:22434 22440.

Send reprint requests to: Dr. Tsung-Ping Su, Cellular Pathobiology Unit, Molecular Neuropsychiatry Section, Intramural Research Program, National Institute on Drug Abuse/National Institutes of Health, 5500 Nathan Shock Dr., Baltimore, MD 21224. E-mail: TSU@intra.nida.nih.gov